ERYTECH Pharma (NASDAQ:ERYP) Shares Up 3.9%

ERYTECH Pharma S.A. (NASDAQ:ERYPGet Rating)’s share price shot up 3.9% during trading on Friday . The stock traded as high as $1.09 and last traded at $1.06. 1,845 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 425,140 shares. The stock had previously closed at $1.02.

ERYTECH Pharma Stock Up 3.9 %

The company has a 50 day moving average of $1.10 and a 200 day moving average of $1.45. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.00 and a quick ratio of 2.00.

ERYTECH Pharma Company Profile

(Get Rating)

ERYTECH Pharma SA, a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients.

Further Reading

Want More Great Investing Ideas?

Receive News & Ratings for ERYTECH Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ERYTECH Pharma and related companies with MarketBeat.com's FREE daily email newsletter.